المؤلفون: Schubert, J, Uciechowski, P, Delany, P, Tischler, HJ, Kolanus, W, Schmidt, RE

المصدر: Blood; September 1990, Vol. 76 Issue: 6 p1181-1187, 7p

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Bittrich M; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany., Kriegsmann K; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; Laborarztpraxis, Laborarztpraxis Rhein-Main MVZ GbR, Limbach Gruppe SE, Frankfurt am Main, Germany., Tietze-Stolley C; Department of Hematology and Oncology, Stem Cell Facility, University Hospital Charité, Berlin, Germany., Movassaghi K; Department of Hematology and Oncology, Stem Cell Facility, University Hospital Charité, Berlin, Germany., Grube M; Department of Hematology and Internistic Oncology, University Hospital Regensburg, Regensburg, Germany., Vucinic V; Klinik und Poliklinik für Hämatologie, Zelltherapie und Hämostaseologie, University Hospital Leipzig, Leipzig, Germany., Wehler D; Klinik und Poliklinik für Innere Medizin III, University Hospital of Mainz, Mainz, Germany., Burchert A; Klinik für Hämatologie, Onkologie und Immunologie, University Hospital of Gießen and Marburg (UKGM), Marburg, Germany., Schmidt-Hieber M; 2. Medizinische Klinik für Hämatologie, Onkologie, Pneumologie und Nephrologie, Carl-Thiem Hospital Cottbus gGmbH, Cottbus, Germany., Rank A; 2. Medizinische Klinik - Hämatologie, Internistische Onkologie und Hämostaseologie, University Hospital of Augsburg, Augsburg, Germany., Dürk HA; Klinik für Hämatologie und Onkologie, St. Barbara Hospital Hamm-Heessen, Hamm, Germany., Metzner B; Universitätsklinik für Innere Medizin - Onkologie und Hämatologie, University Hospital Klinikum Oldenburg, Oldenburg, Germany., Kimmich C; Universitätsklinik für Innere Medizin - Onkologie und Hämatologie, University Hospital Klinikum Oldenburg, Oldenburg, Germany., Hentrich M; Abteilung für Innere Medizin III - Hämatologie und Onkologie, Rotkreuzklinikum München, Munich, Germany., Kunz C; Innere Medizin I, Westpfalz-Klinikum Kaiserslautern, Kaiserslautern, Germany., Hartmann F; Klinik für Onkologie und Hämatologie, Hospital Lippe-Lemgo, Lemgo, Germany., Khandanpour C; Medizinische Klinik A, University Hospital Münster, Münster, Germany.; Klinik für Hämatologie und Onkologie, University Hospital Schleswig-Holstein (Campus Lübeck) and University of Lübeck, Lübeck, Germany., de Wit M; Klinik für Innere Medizin - Hämatologie, Onkologie und Palliativmedizin, Vivantes Hospital Neukölln, Berlin, Germany., Holtick U; Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany., Kiehl M; Medizinische Klinik I, Hospital Frankfurt (Oder), Frankfurt an der Oder, Germany., Stoltefuß A; Klinik für Innere Medizin II, Evangelisches Krankenhaus Hamm, Hamm, Germany., Kiani A; Department of Hematology and Oncology, Klinikum Bayreuth, Bayreuth, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany., Naumann R; Klinik für Hämatologie, Medizinische Onkologie und Palliativmedizin, St. Marien-Krankenhaus Marien Gesellschaft Siegen gGmbH, Siegen, Germany., Scholz CW; Klinik für Innere Medizin - Hämatologie und Onkologie, Vivantes Hospital Am Urban, Berlin, Germany., Tischler HJ; Universitätsklinik für Hämatologie, Onkologie, Hämostaseologie und Palliativmedizin, Johannes Wesling Hospital Minden, Mühlenkreiskliniken, Minden, Germany., Görner M; Klinik für Hämatologie, Onkologie, Palliativmedizin und Stammzelltherapie, Hospital Bielefeld-Mitte, Bielefeld, Germany., Brand F; Sanofi-Aventis Deutschland GmbH, Berlin, Germany., Ehmer M; Sanofi-Aventis Deutschland GmbH, Berlin, Germany., Kröger N; Interdisziplinäre Klinik und Poliklinik für Stammzelltransplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

المصدر: Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie [Transfus Med Hemother] 2023 Oct 16; Vol. 50 (6), pp. 475-490. Date of Electronic Publication: 2023 Oct 16 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101176417 Publication Model: eCollection Cited Medium: Print ISSN: 1660-3796 (Print) Linking ISSN: 16603796 NLM ISO Abbreviation: Transfus Med Hemother Subsets: PubMed not MEDLINE

المؤلفون: Kriegsmann K; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.; Laborarztpraxis, Laborarztpraxis Rhein-Main MVZ GbR, Limbach Gruppe SE, Frankfurt, Germany., Bittrich M; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany., Sauer S; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany., Tietze-Stolley C; Department of Hematology and Oncology, Stem Cell Facility, University Hospital Charité, Berlin, Germany., Movassaghi K; Department of Hematology and Oncology, Stem Cell Facility, University Hospital Charité, Berlin, Germany., Grube M; Department of Hematology and Internistic Oncology, University Hospital Regensburg, Regensburg, Germany., Vucinic V; Klinik und Poliklinik für Hämatologie, Zelltherapie und Hämostaseologie, University Hospital Leipzig, Leipzig, Germany., Wehler D; Klinik und Poliklinik für Innere Medizin III, University Hospital of Mainz, Mainz, Germany., Burchert A; Klinik für Hämatologie, Onkologie und Immunologie, University Hospital of Gießen and Marburg (UKGM), Marburg, Germany., Schmidt-Hieber M; 2. Medizinische Klinik für Hämatologie, Onkologie, Pneumologie und Nephrologie, Carl-Thiem Hospital Cottbus gGmbH, Cottbus, Germany., Rank A; 2. Medizinische Klinik - Hämatologie, Internistische Onkologie und Hämostaseologie, University Hospital of Augsburg, Augsburg, Germany., Dürk HA; Klinik für Hämatologie und Onkologie, St. Barbara Hospital Hamm-Heessen, Hamm, Germany., Metzner B; Universitätsklinik für Innere Medizin - Onkologie und Hämatologie, University Hospital Klinikum Oldenburg, Oldenburg, Germany., Kimmich C; Universitätsklinik für Innere Medizin - Onkologie und Hämatologie, University Hospital Klinikum Oldenburg, Oldenburg, Germany., Hentrich M; Abteilung für Innere Medizin III -Hämatologie und Onkologie, Rotkreuzklinikum München, Munich, Germany., Kunz C; Innere Medizin I, Westpfalz-Klinikum Kaiserslautern, Kaiserslautern, Germany., Hartmann F; Klinik für Onkologie und Hämatologie, Hospital Lippe-Lemgo, Lemgo, Germany., Khandanpour C; Medizinische Klinik A, University Hospital Münster, Münster, Germany.; Klinik für Hämatologie und Onkologie, University Hospital Schleswig-Holstein (Campus Lübeck) and University of Lübeck, Lübeck, Germany., de Wit M; Klinik für Innere Medizin - Hämatologie, Onkologie und Palliativmedizin, Vivantes Hospital Neukölln, Berlin, Germany., Holtick U; Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany., Kiehl M; Medizinische Klinik I, Hospital Frankfurt (Oder), Frankfurt/Oder, Germany., Stoltefuß A; Klinik für Innere Medizin II, Evangelisches Krankenhaus Hamm, Hamm, Germany., Kiani A; Department of Hematology and Oncology, Klinikum Bayreuth, Bayreuth, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany., Naumann R; Klinik für Hämatologie, Medizinische Onkologie und Palliativmedizin, St. Marien-Krankenhaus Marien Gesellschaft Siegen gGmbH, Siegen, Germany., Scholz CW; Klinik für Innere Medizin - Hämatologie und Onkologie, Vivantes Hospital Am Urban, Berlin, Germany., Tischler HJ; Universitätsklinik für Hämatologie, Onkologie, Hämostaseologie und Palliativmedizin, Johannes Wesling Hospital Minden, Mühlenkreiskliniken, Minden, Germany., Görner M; Klinik für Hämatologie, Onkologie, Palliativmedizin und Stammzelltherapie, Hospital Bielefeld-Mitte, Bielefeld, Germany., Brand F; Sanofi-Aventis Deutschland GmbH, Berlin, Germany., Ehmer M; Sanofi-Aventis Deutschland GmbH, Berlin, Germany., Kröger N; Interdisziplinäre Klinik und Poliklinik für Stammzelltransplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

المصدر: Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie [Transfus Med Hemother] 2023 Sep 21; Vol. 50 (5), pp. 403-416. Date of Electronic Publication: 2023 Sep 21 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101176417 Publication Model: eCollection Cited Medium: Print ISSN: 1660-3796 (Print) Linking ISSN: 16603796 NLM ISO Abbreviation: Transfus Med Hemother Subsets: PubMed not MEDLINE

المؤلفون: Schlenk RF; NCT-Trial Center, National Center of Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany. richard.schlenk@nct-heidelberg.de.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany. richard.schlenk@nct-heidelberg.de., Weber D; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Krzykalla J; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany., Kindler T; Department of Hematology, Medical Oncology and Pneumology, University Medical Center Mainz, Mainz, Germany., Wulf G; Department of Hematology and Oncology, University Hospital of Göttingen, Göttingen, Germany., Hertenstein B; Department of Hematology and Oncology, Klinikum Bremen Mitte, Bremen, Germany., Salih HR; Department of Hematology and Oncology, Eberhard-Karls University, Tübingen, Germany., Südhoff T; Department of Hematology and Oncology, Klinikum Passau, Passau, Germany., Krauter J; Department Hematology and Oncology, Braunschweig Municipal Hospital, Braunschweig, Germany., Martens U; Department of Hematology and Oncology, Klinikum am Gesundbrunnen, Heilbronn, Germany., Wessendorf S; Department of Hematology and Oncology, Klinikum Esslingen, Esslingen, Germany., Runde V; Department of Hematology/Oncology, Wilhelm-Anton Hospital Goch, Goch, Germany., Tischler HJ; Department of Hematology and Oncology, University Hospital of Minden, Minden, Germany., Bentz M; Department of Hematology and Oncology, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany., Koller E; Department of Internal Medicine III, Hanuschkrankenhaus Wien, Wien, Austria., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Thol F; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Benner A; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany., Ganser A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Döhner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.

المصدر: Scientific reports [Sci Rep] 2023 Sep 08; Vol. 13 (1), pp. 14809. Date of Electronic Publication: 2023 Sep 08.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics, Humans ; Aged ; Etoposide/adverse effects ; Cytarabine/adverse effects ; Tretinoin/therapeutic use ; Nuclear Proteins

المؤلفون: Döhner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Weber D; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Krzykalla J; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Fiedler W; Hubertus Wald University Cancer Center, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Wulf G; Department of Hematology and Oncology, Georg-August-University Göttingen, Göttingen, Germany., Salih H; Department of Hematology and Oncology, Eberhard-Karls University, Tübingen, Germany., Lübbert M; Department of Medicine I, Medical Center - University of Freiburg, Freiburg, Germany., Kühn MWM; Department of Hematology, Medical Oncology & Pneumology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany., Schroeder T; Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany., Salwender H; Department of Oncology and Hematology, Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany., Götze K; Department of Medicine III, Hematology and Medical Oncology, Technical University of Munich, Munich, Germany., Westermann J; Department of Hematology, Oncology and Tumorimmunology, Charité University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany., Fransecky L; Department of Internal Medicine II, University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany., Mayer K; Department of Hematology, Oncology, University Hospital Bonn, Bonn, Germany., Hertenstein B; Department of Hematology and Oncology, Klinikum Bremen-Mitte, Bremen, Germany., Ringhoffer M; Department of Internal Medicine III, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany., Tischler HJ; Department of Hematology and Oncology, University Hospital of Minden, Minden, Germany., Machherndl-Spandl S; Department of Hematology and Oncology, Hospital Elisabethinen Linz, Linz, Austria., Schrade A; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Paschka P; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Gaidzik VI; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Theis F; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Thol F; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Schlenk RF; National Center of Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Bullinger L; Department of Hematology, Oncology and Tumorimmunology, Charité University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany., Saadati M; Freelance Statistician, Saadati Solutions, Ladenburg, Germany., Benner A; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Larson R; Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL; and., Stone R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Ganser A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.

المصدر: Blood advances [Blood Adv] 2022 Sep 27; Vol. 6 (18), pp. 5345-5355.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/methods , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics, Adolescent ; Adult ; Aged ; Humans ; Middle Aged ; Protein-Tyrosine Kinases ; Staurosporine/adverse effects ; Staurosporine/analogs & derivatives ; Young Adult ; fms-Like Tyrosine Kinase 3/genetics ; fms-Like Tyrosine Kinase 3/therapeutic use

المؤلفون: Merz M; Medizinische Klinik V, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. maximilian.merz@med.uni-heidelberg.de., Kellermann L; Oncology Information Service, Freiburg, Germany., Poenisch W; Universitätsklinikum Leipzig, Leipzig, Germany., Tischler HJ; Johannes Wesling Klinikum Minden, Minden, Germany., Kohnke J; Onkologische Praxis Remscheid, Remscheid, Germany., Knauf W; Onkologie Bethanien, Frankfurt/Main, Germany., Goldschmidt H; Medizinische Klinik V, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Nationales Centrum für Tumorerkrankungen (NCT), Heidelberg, Germany.

المصدر: Annals of hematology [Ann Hematol] 2017 Jun; Vol. 96 (6), pp. 987-993. Date of Electronic Publication: 2017 Apr 13.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Hematopoietic Stem Cell Transplantation/*methods , Multiple Myeloma/*diagnosis , Multiple Myeloma/*therapy, Adult ; Aged ; Aged, 80 and over ; Bortezomib/administration & dosage ; Cardiovascular Diseases/epidemiology ; Comorbidity ; Diabetes Mellitus/epidemiology ; Female ; Germany/epidemiology ; Health Surveys/methods ; Health Surveys/statistics & numerical data ; Humans ; Lenalidomide ; Male ; Middle Aged ; Multiple Myeloma/epidemiology ; Neoplasm Recurrence, Local ; Thalidomide/administration & dosage ; Thalidomide/analogs & derivatives ; Transplantation, Autologous

المؤلفون: Röllig C; Medizinische Klinik und Poliklinik I, Universitätsklinikum Dresden, Dresden, Germany. christoph.roellig@uniklinikumdresden.de, Bornhäuser M, Thiede C, Taube F, Kramer M, Mohr B, Aulitzky W, Bodenstein H, Tischler HJ, Stuhlmann R, Schuler U, Stölzel F, von Bonin M, Wandt H, Schäfer-Eckart K, Schaich M, Ehninger G

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2011 Jul 10; Vol. 29 (20), pp. 2758-65. Date of Electronic Publication: 2011 May 31.

نوع المنشور: Comparative Study; Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Cytogenetic Analysis* , Practice Guidelines as Topic*, Biomarkers, Tumor/*genetics , Leukemia, Myeloid, Acute/*diagnosis , Leukemia, Myeloid, Acute/*genetics , Population Surveillance/*methods, Adolescent ; Adult ; Age Distribution ; Aged ; Aged, 80 and over ; Europe/epidemiology ; Female ; Follow-Up Studies ; Germany/epidemiology ; Humans ; Leukemia, Myeloid, Acute/mortality ; Male ; Middle Aged ; Prognosis ; Risk Assessment ; Survival Analysis